Site updated at Wednesday, 22 June 2016

Living with Dementia

Cognitive Dysfunction

Cognition and Cognitive Testing

As noted above, the diagnoses of mild cognitive impairment and dementia of the Alzheimer type both require the presence of memory impairment. To distinguish between MCI and DAT, it is important to determine the degree and course of memory impairment, the presence or absence of additional domains of cognitive dysfunction, and the impact of… Cognition and Cognitive Testing   

Nutritional intervention helps in mild Alzheimer’s disease

A second clinical trial of the medical food Souvenaid confirmed that daily intake of the nutritional intervention improves memory in people with mild Alzheimer’s disease (AD). Results of the trial - called Souvenir II - were presented at the 4th International Conference on Clinical Trials in Alzheimer’s Disease (CTAD) in San Diego, California on… Nutritional intervention helps in mild Alzheimer’s disease   

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   

New mouse model could revolutionize research in Alzheimer’s disease

Alzheimer’s disease, the primary cause of dementia in the elderly, imposes a tremendous social and economic burden on modern society. In Japan, the burden of the disease in 2050 is estimated to be a half a trillion US dollars, a figure equivalent to the government’s annual revenues.

Unfortunately, it has proven very difficult to… New mouse model could revolutionize research in Alzheimer’s disease   

Parkinson’s Disease Dementia

amyloid beta precursor protein1 - parkinsons diagnosis1 - high-cholesterol diet1 - sodium benzoate1 - signs of alzheimer's1 - early-onset alzheimer's1 - memory disorders program1 - neurofilaments1 - dementia changes1 - gum disease1 - melancholia2 - hiv dementia1 - tau3 - emotional distress1 - university of california2 - mood swings1 - decline in cognitive functioning1 - immune globulin1 - penn medicine1 - alzheimer's disease biomarkers1 - physical function1 - senile dementia4 - cognitive functions1 - syndrome of dementia1 - amyloid beta8 - vesanic dementia2 - reducing anxiety1 - coronary heart disease1 - schizophrenia1 - clinical conclusions1 -